Monday, July 18, 2011
Common Bone Drug May Help Prevent Breast Cancer Recurrence
New study suggests early stage breast cancer patients taking Zometa with their hormone therapy may reduce their risk of recurrence.
An RSS feed for the weekly update of relevant headlines from TheBreastCareSite.com